Deakin University
Browse

File(s) under permanent embargo

Engagement and weightloss: results from the mobile health and diabetes trial

journal contribution
posted on 2019-09-01, 00:00 authored by Shruti Muralidharan, H Ranjani, R Mohan Anjana, S Jena, N Tandon, Y Gupta, S Ambekar, V Koppikar, N Jagannathan, Steven AllenderSteven Allender, V Mohan
© Copyright 2019, Mary Ann Liebert, Inc., publishers. Background: Prevalence of type 2 diabetes (T2D) is increasing worldwide. Identifying and targeting individuals at high risk, is essential for preventing T2D. Several studies point to mobile health initiatives delivered through personal smart devices being a promising approach to diabetes prevention, through weight loss. The aim of the mobile health and diabetes (mDiab) trial was twofold: to achieve 5% weight loss and to look at the association of weight loss with degree of engagement with the mDiab app. Methods: The mDiab randomized control trial was carried out among smartphone users who are at high risk for T2D mellitus in three cities - Chennai, Bengaluru, and New Delhi in India. The intervention was delivered through a mobile phone application along with weekly coach calls for 12 weeks. While individuals in the intervention group individuals received the app, which enabled tracking their weight, physical activity, and diet along with 12 weekly video lessons on T2D prevention and coach calls, the control group received usual care. Results: The intervention group experienced a significant 1 kg weight loss while the control group lost 0.3 kg (P < 0.05). More individuals in the intervention group (n = 139, 15%) met the 5% weight loss target than in the control group (n = 131, 9%). In the intervention group those who viewed the videos experienced greater weight loss (2.4 kg) than those who only attended coach calls (0.9 kg) (P < 0.01). Conclusions: An mHealth intervention helped to achieve moderate weight loss. Future studies should explore the sustainability of this weight loss.

History

Journal

Diabetes technology and therapeutics

Volume

21

Issue

9

Pagination

507 - 513

Publisher

Mary Ann Liebert, Inc.

Location

New York, N.Y.

ISSN

1520-9156

eISSN

1557-8593

Language

eng

Publication classification

C1 Refereed article in a scholarly journal

Usage metrics

    Research Publications

    Categories

    No categories selected

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC